Clinical Trials Logo

Clinical Trial Summary

Study question: Is there an ideal combination of intraoperative long acting analgesics (periarticular infiltration (PI), femoral nerve block (FB) and intrathecal opioids (IO)) to optimize post-operative functional recovery, decrease overall narcotic consumption and enable faster 'readiness to discharge' for patients undergoing primary total knee replacement (TKR)?


Clinical Trial Description

Our study design is a five-arm double blinded randomized control trial. In order to create a blinded study, each participant will have all three interventions (Femoral Nerve Block (FB), Periarticular Injection (PI) and Intrathecal Opioid (IO)) performed during their visit. Normal saline (NS) will be substituted for opioid or local anesthetic in cases where a control is required.

Specific 5 arms include:

- Using all three anesthetics:

o PI + FB + IO (arm 1)

- Using a combination of two anesthetics + normal saline substitute for control:

- NS + FB + IO (arm 2)

- PI + NS + IO (arm 3)

- PI + FB + NS (arm 4)

- Control:

- NS + NS + IO (arm 5)

The control arm would include IO as the sole intervention as this is simply added to the spinal anesthetic used for the surgery itself. It is felt that having a study arm without any long-acting analgesic medication (opioid or local anesthetic) as the "control" arm following a spinal anesthetic would not meet current standard of care and cause harm to the participant

The investigators hypothesize that the combination of three forms of long acting analgesia (PI, FB, IO) will result in the greatest outcomes compared to a combination of any two or control. Our aim is to demonstrate that this optimal analgesic combination will have an additive pain control effect and will minimize side effects thus translating to less acute pain, improve patient mobility, and attaining "readiness to discharge" quicker. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02474654
Study type Interventional
Source Health Sciences North Research Institute
Contact
Status Completed
Phase Phase 4
Start date July 2015
Completion date January 14, 2019

See also
  Status Clinical Trial Phase
Completed NCT04090125 - Improving Physical Activity and Gait Symmetry After Total Knee Arthroplasty N/A
Recruiting NCT05490186 - Function, Pain, and Alignment Following Knee Replacement for the Treatment of Osteoarthritis N/A
Completed NCT03492320 - Progression of Health Related Quality of Life of Patients Waiting for Total Knee Arthroplasty
Terminated NCT02830087 - Tourniquet Pressure in Primary Total Knee Arthroplasty N/A
Completed NCT04286035 - Two Different Blocks for Postoperative Analgesia in Patients Undergoing Unilateral Total Knee Arthroplasty Phase 4